Full text is available at the source.
Abstract
Retatrutide, an investigational drug, may be useful for treating painful knee osteoarthritis in individuals with obesity.
- Retatrutide targets three hormonal receptors: GIP, GLP-1, and glucagon.
- Painful knee osteoarthritis is a common condition, especially among people with obesity.
- The potential effectiveness of retatrutide for this condition is currently under investigation.
Simplified